The DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
The interaction of innate immune and adaptive immune system
Open accessAbstract
The innate immune system serves as the body's first line of defense, utilizing pattern recognition receptors like Toll‐like receptors to detect pathogens and initiate rapid response mechanisms. Following this initial response, adaptive immunity provides highly specific and sustained killing of pathogens via B cells, T cells, and antibodies. Traditionally, it has been assumed that innate immunity activates adaptive immunity; however, recent studies have revealed more complex interactions. This review provides a detailed dissection of the composition and function of the innate and adaptive immune systems, emphasizing their synergistic roles in physiological and pathological contexts, providing new insights into the link between these two forms of immunity. Precise regulation of both immune systems at the same time is more beneficial in the fight against immune‐related diseases, for example, the cGAS–STING pathway has been found to play an important role in infections and cancers. In addition, this paper summarizes the challenges and future directions in the field of immunity, including the latest single‐cell sequencing technologies, CAR‐T cell therapy, and immune checkpoint inhibitors. By summarizing these developments, this review aims to enhance our understanding of the complexity interactions between innate and adaptive immunity and provides new perspectives in understanding the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · cited 2×
“243 On the other hand, the of mRNA vaccines is yet to be proven.”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023184 · Cited by 2,745
Defining trained immunity and its role in health and disease
Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L. A. B., van der Meer, J. W. M., Mhlanga, M. M., Mulder, W. J. M., et al. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0285-6 · Cited by 2,690
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Murphy, K., & Weaver, C. (2016) · W.W. Norton eBooks · doi:10.1201/9781315533247 · Cited by 2,258
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Liu, E., Marin, D., Banerjee, P., Macapinlac, H. A., Thompson, P., Basar, R., Nassif Kerbauy, L., Overman, B., Thall, P., Kaplan, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910607 · Cited by 2,217
Control of adaptive immunity by the innate immune system
Iwasaki, A., & Medzhitov, R. (2015) · Nature Immunology · doi:10.1038/ni.3123 · Cited by 2,160
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,157
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Schadendorf, D., Hodi, F. S., Robert, C., Weber, J. S., Margolin, K., Hamid, O., Patt, D., Chen, T.-T., Berman, D. M., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2736 · Cited by 2,141
Innate Lymphoid Cells: 10 Years On
Vivier, E., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.017 · Cited by 2,124
The microbiome and innate immunity
Thaiss, C. A., Zmora, N., Levy, M., & Elinav, E. (2016) · Nature · doi:10.1038/nature18847 · Cited by 2,012
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,905
The development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
IgE, mast cells, basophils, and eosinophils
Stone, K. D., Prussin, C., & Metcalfe, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.017 · Cited by 1,680
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Up on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
Neutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,573
Human chimeric antigen receptor macrophages for cancer immunotherapy
Klichinsky, M., Ruella, M., Shestova, O., Lu, X. M., Best, A., Zeeman, M., Schmierer, M., Gabrusiewicz, K., Anderson, N. R., Petty, N. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0462-y · Cited by 1,495
The generation of antibody-secreting plasma cells
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3795 · Cited by 1,454
Long-term outcomes following CAR T cell therapy: what we know so far
Cappell, K. M., & Kochenderfer, J. N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00754-1 · Cited by 1,382
HOW TCRS BIND MHCS, PEPTIDES, AND CORECEPTORS
Rudolph, M. G., Stanfield, R. L., & Wilson, I. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115658 · Cited by 1,310
Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
Wei, S. C., Levine, J. H., Cogdill, A. P., Zhao, Y., Anang, N.-A. A. S., Andrews, M. C., Sharma, P., Wang, J., Wargo, J. A., Pe’er, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.024 · Cited by 1,302
NK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
Immune checkpoint therapy—current perspectives and future directions
Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.006 · Cited by 1,206
The technological landscape and applications of single-cell multi-omics
Baysoy, A., Bai, Z., Satija, R., & Fan, R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00615-w · Cited by 1,037
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
Duan, T., Du, Y., Xing, C., Wang, H. Y., & Wang, R.-F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.812774 · Cited by 972
Self-citationHow are TH2-type immune responses initiated and amplified?
Paul, W. E., & Zhu, J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2735 · Cited by 963
Epithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3228 · Cited by 957
The cancer-immunity cycle: Indication, genotype, and immunotype
Mellman, I., Chen, D. S., Powles, T., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 953
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
Melenhorst, J. J., Chen, G. M., Wang, M., Porter, D. L., Chen, C., Collins, M. A., Gao, P., Bandyopadhyay, S., Sun, H., Zhao, Z., et al. (2022) · Nature · doi:10.1038/s41586-021-04390-6 · Cited by 923
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
TGF-β: A Master of All T Cell Trades
Li, M. O., & Flavell, R. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.025 · Cited by 893
Le, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 873
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Pittock, S. J., Berthele, A., Fujihara, K., Kim, H. J., Levy, M., Palace, J., Nakashima, I., Terzi, M., Totolyan, N., Viswanathan, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900866 · Cited by 872
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864 · cited 1×
“47,48 Following the formation and activation of C3 conver-tase, subsequent cascade reactions, including the formation of C5 convertase, can exert cytolytic effects, mediate inflammation, opsonize pathogens, and clear immune complexes.”
BackgroundLeisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V., Mastroiani, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 855
Liu, E., Tong, Y., Dotti, G., Shaim, H., Savoldo, B., Mukherjee, M., Orange, J., Wan, X., Lu, X., Reynolds, A., et al. (2018) · Leukemia · doi:10.1038/leu.2017.226 · Cited by 824
The crucial roles of inflammatory mediators in inflammation: A review
Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H., & Hezmee, M. N. M. (2018) · Veterinary World · doi:10.14202/vetworld.2018.627-635 · Cited by 775
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Regulation of macrophage development and function in peripheral tissues
Lavin, Y., Mortha, A., Rahman, A., & Merad, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3920 · Cited by 680
The many important facets of T-cell repertoire diversity
Nikolich-Žugich, J., Slifka, M. K., & Messaoudi, I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1292 · Cited by 675
Central tolerance: learning self-control in the thymus
Hogquist, K. A., Baldwin, T. A., & Jameson, S. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1707 · Cited by 659
Immunological decision‐making: how does the immune system decide to mount a helper T‐cell response?
Kaiko, G. E., Horvat, J. C., Beagley, K. W., & Hansbro, P. M. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02719.x · Cited by 658
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Pan, K., Farrukh, H., Chittepu, V. C. S. R., Xu, H., Pan, C.-X., & Zhu, Z. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02327-z · Cited by 657
Godfrey, D. I., Stankovic, S., & Baxter, A. G. (2010) · Nature Immunology · doi:10.1038/ni.1841 · Cited by 649
Pathogenesis of autoimmune disease
Pisetsky, D. S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00720-1 · Cited by 649
Lee (2019) · doi:10.1038/s12276-019-0299-y · Cited by 635
Haas, K. M., Poe, J. C., Steeber, D. A., & Tedder, T. F. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.011 · Cited by 628
B-cell biology and development
Pieper, K., Grimbacher, B., & Eibel, H. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.046 · Cited by 615
Natural killer cells act as rheostats modulating antiviral T cells
Waggoner, S. N., Cornberg, M., Selin, L. K., & Welsh, R. M. (2012) · Nature · doi:10.1038/nature10624 · Cited by 607
Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response
Pape, K. A., Taylor, J. J., Maul, R. W., Gearhart, P. J., & Jenkins, M. K. (2011) · Science · doi:10.1126/science.1201730 · Cited by 572
The cancer–natural killer cell immunity cycle
Huntington, N. D., Cursons, J., & Rautela, J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0272-z · Cited by 566
Mirza, N., Fishman, M., Fricke, I., Dunn, M., Neuger, A. M., Frost, T. J., Lush, R. M., Antonia, S., & Gabrilovich, D. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1690 · Cited by 564
Turvey, S. E., & Broide, D. H. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.016 · Cited by 557
The role of the complement system in cancer
Afshar-Kharghan, V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90962 · Cited by 554
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Blimark, C., Holmberg, E., Mellqvist, U.-H., Landgren, O., Bjorkholm, M., Hultcrantz, M., Kjellander, C., Turesson, I., & Kristinsson, S. Y. (2015) · Haematologica · doi:10.3324/haematol.2014.107714 · Cited by 524
DAMPs and DAMP-sensing receptors in inflammation and diseases
Ma, M., Jiang, W., & Zhou, R. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.002 · Cited by 515
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Bald, T., Krummel, M. F., Smyth, M. J., & Barry, K. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0728-z · Cited by 506
CAR T therapy beyond cancer: the evolution of a living drug
Baker, D. J., Arany, Z., Baur, J. A., Epstein, J. A., & June, C. H. (2023) · Nature · doi:10.1038/s41586-023-06243-w · Cited by 504
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Wang, D.-R., Wu, X.-L., & Sun, Y.-L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01136-2 · Cited by 501
The promise of mRNA vaccines: a biotech and industrial perspective
Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan, S., & DeRosa, F. (2020) · npj Vaccines · doi:10.1038/s41541-020-0159-8 · Cited by 498 · cited 1×
“267 In contrast to DNA vaccines, mRNA vaccines mitigate the risk of insertional mutagenesis in the host genome and can modulate antigen expression.”
BackgroundThe mechanism of action of MF59 – An innately attractive adjuvant formulation
O’Hagan, D. T., Ott, G. S., De Gregorio, E., & Seubert, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.09.061 · Cited by 488
Immunologic messenger molecules: Cytokines, interferons, and chemokines
Commins, S. P., Borish, L., & Steinke, J. W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.008 · Cited by 479
New insights into the immune functions of complement
Reis, E. S., Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0168-x · Cited by 470
The role of eosinophils in host defense against helminth parasites
Klion, A. D., & Nutman, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.050 · Cited by 463
Carthon, B. C., Wolchok, J. D., Yuan, J., Kamat, A., Ng Tang, D. S., Sun, J., Ku, G., Troncoso, P., Logothetis, C. J., Allison, J. P., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0569 · Cited by 460
Gabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999) · PubMed · Cited by 459
Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070695 · Cited by 455
TLR-dependent T cell activation in autoimmunity
Mills, K. H. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3095 · Cited by 443
Re(de)fining the dendritic cell lineage
Satpathy, A. T., Wu, X., Albring, J. C., & Murphy, K. M. (2012) · Nature Immunology · doi:10.1038/ni.2467 · Cited by 441
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Tran Janco, J. M., Lamichhane, P., Karyampudi, L., & Knutson, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403134 · Cited by 440
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Xu-Monette, Z. Y., Zhou, J., & Young, K. H. (2018) · Blood · doi:10.1182/blood-2017-07-740993 · Cited by 433
Complement and Its Receptors: New Insights into Human Disease
Holers, V. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120154 · Cited by 430
Functions of fungal melanin beyond virulence
Cordero, R. J. B., & Casadevall, A. (2017) · Fungal Biology Reviews · doi:10.1016/j.fbr.2016.12.003 · Cited by 416
Chimeric antigen receptors that trigger phagocytosis
Morrissey, M. A., Williamson, A. P., Steinbach, A. M., Roberts, E. W., Kern, N., Headley, M. B., & Vale, R. D. (2018) · eLife · doi:10.7554/elife.36688 · Cited by 404
Mashayekhi, M., Sandau, M. M., Dunay, I. R., Frickel, E. M., Khan, A., Goldszmid, R. S., Sher, A., Ploegh, H. L., Murphy, T. L., Sibley, L. D., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.008 · Cited by 403
The WHO fungal priority pathogens list as a game-changer
Fisher, M. C., & Denning, D. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00861-x · Cited by 399
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389
Taylor, J. J., Pape, K. A., & Jenkins, M. K. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111696 · Cited by 387
Palm, N. W., Rosenstein, R. K., & Medzhitov, R. (2012) · Nature · doi:10.1038/nature11047 · Cited by 352
B-1 B Cell Development in the Fetus and Adult
Montecino-Rodriguez, E., & Dorshkind, K. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.017 · Cited by 351
Development of Dendritic-Cell Lineages
Wu, L., & Liu, Y.-J. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.006 · Cited by 343
Terawaki, S., Chikuma, S., Shibayama, S., Hayashi, T., Yoshida, T., Okazaki, T., & Honjo, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003208 · Cited by 342
Innate-adaptive immunity interplay and redox regulation in immune response
Sun, L., Wang, X., Saredy, J., Yuan, Z., Yang, X., & Wang, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101759 · Cited by 340
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle
Fridman, W. H., Meylan, M., Pupier, G., Calvez, A., Hernandez, I., & Sautès-Fridman, C. (2023) · Immunity · doi:10.1016/j.immuni.2023.08.009 · Cited by 326
Skin Barrier Function and the Microbiome
Lee, H.-J., & Kim, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113071 · Cited by 317
Liu, Y. J., Malisan, F., de Bouteiller, O., Guret, C., Lebecque, S., Banchereau, J., Mills, F. C., Max, E. E., & Martinez-Valdez, H. (1996) · Immunity · doi:10.1016/s1074-7613(00)80432-x · Cited by 310
Immunogenicity of CAR T cells in cancer therapy
Wagner, D. L., Fritsche, E., Pulsipher, M. A., Ahmed, N., Hamieh, M., Hegde, M., Ruella, M., Savoldo, B., Shah, N. N., Turtle, C. J., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00476-2 · Cited by 303
Huleatt, J. W., Jacobs, A. R., Tang, J., Desai, P., Kopp, E. B., Huang, Y., Song, L., Nakaar, V., & Powell, T. J. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.013 · Cited by 299
Veltman, J. D., Lambers, M. E., van Nimwegen, M., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G., & Hegmans, J. P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-464 · Cited by 291
Wang, N., Zhan, Y., Zhu, L., Hou, Z., Liu, F., Song, P., Qiu, F., Wang, X., Zou, X., Wan, D., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.005 · Cited by 287
Greene, S., Robbins, Y., Mydlarz, W. K., Huynh, A. P., Schmitt, N. C., Friedman, J., Horn, L. A., Palena, C., Schlom, J., Maeda, D. Y., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2625 · Cited by 280
Granit, V., Benatar, M., Kurtoglu, M., Miljković, M. D., Chahin, N., Sahagian, G., Feinberg, M. H., Slansky, A., Vu, T., Jewell, C. M., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00194-1 · Cited by 280
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination
Wimmers, F., Donato, M., Kuo, A., Ashuach, T., Gupta, S., Li, C., Dvorak, M., Foecke, M. H., Chang, S. E., Hagan, T., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.039 · Cited by 276
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
Frey, N. V., Shaw, P. A., Hexner, E. O., Pequignot, E., Gill, S., Luger, S. M., Mangan, J. K., Loren, A. W., Perl, A. E., Maude, S. L., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01892 · Cited by 271
Kamburova, E. G., Koenen, H. J. P. M., Borgman, K. J. E., ten Berge, I. J., Joosten, I., & Hilbrands, L. B. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12220 · Cited by 257
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00734-z · Cited by 255
Complosome — the intracellular complement system
West, E. E., & Kemper, C. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00704-1 · Cited by 253
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Chao, M. P., Takimoto, C. H., Feng, D. D., McKenna, K., Gip, P., Liu, J., Volkmer, J.-P., Weissman, I. L., & Majeti, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01380 · Cited by 252
Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
Lee, N., Zakka, L. R., Mihm, M. C., & Schatton, T. (2016) · Pathology · doi:10.1016/j.pathol.2015.12.006 · Cited by 250
IL-15 in the Combination Immunotherapy of Cancer
Waldmann, T. A., Dubois, S., Miljkovic, M. D., & Conlon, K. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00868 · Cited by 247
mRNA vaccines in disease prevention and treatment
Zhang, G., Tang, T., Chen, Y., Huang, X., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01579-1 · Cited by 241
Trial watch: TLR3 agonists in cancer therapy
Le Naour, J., Galluzzi, L., Zitvogel, L., Kroemer, G., & Vacchelli, E. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1771143 · Cited by 239 · cited 1×
“191 Immunosup-pressive signaling includes various factors such as TGF-β , IL-10, IDO, PGE2, and VEGF, which impair DC function, disrupt immune surveillance, and facilitate tumor progression.”
BackgroundPattern recognition receptors in antifungal immunity
Plato, A., Hardison, S. E., & Brown, G. D. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0462-4 · Cited by 232
Somatosensory and autonomic neuronal regulation of the immune response
Udit, S., Blake, K., & Chiu, I. M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00555-4 · Cited by 231
Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
Ochoa, M. C., Minute, L., Rodriguez, I., Garasa, S., Perez‐Ruiz, E., Inogés, S., Melero, I., & Berraondo, P. (2017) · Immunology & Cell Biology · doi:10.1038/icb.2017.6 · Cited by 230
Inoue, T., & Kurosaki, T. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00897-3 · Cited by 227
Exploiting innate immunity for cancer immunotherapy
Yi, M., Li, T., Niu, M., Mei, Q., Zhao, B., Chu, Q., Dai, Z., & Wu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01885-w · Cited by 225
Seider, K., Brunke, S., Schild, L., Jablonowski, N., Wilson, D., Majer, O., Barz, D., Haas, A., Kuchler, K., Schaller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003730 · Cited by 220
Kang, M., Lee, S. H., Kwon, M., Byun, J., Kim, D., Kim, C., Koo, S., Kwon, S. P., Moon, S., Jung, M., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103258 · Cited by 219
Guy, C., Mitrea, D. M., Chou, P.-C., Temirov, J., Vignali, K. M., Liu, X., Zhang, H., Kriwacki, R., Bruchez, M. P., Watkins, S. C., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01176-4 · Cited by 213
The SIRPα–CD47 immune checkpoint in NK cells
Deuse, T., Hu, X., Agbor-Enoh, S., Jang, M. K., Alawi, M., Saygi, C., Gravina, A., Tediashvili, G., Nguyen, V. Q., Liu, Y., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200839 · Cited by 209
Pepini, T., Pulichino, A.-M., Carsillo, T., Carlson, A. L., Sari-Sarraf, F., Ramsauer, K., Debasitis, J. C., Maruggi, G., Otten, G. R., Geall, A. J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601877 · Cited by 208
A guide to adaptive immune memory
Lam, N., Lee, Y., & Farber, D. L. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01040-6 · Cited by 208
STING-associated vasculopathy develops independently of IRF3 in mice
Warner, J. D., Irizarry-Caro, R. A., Bennion, B. G., Ai, T. L., Smith, A. M., Miner, C. A., Sakai, T., Gonugunta, V. K., Wu, J., Platt, D. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171351 · Cited by 206
COVID-19 and emerging viral infections: The case for interferon lambda
Prokunina-Olsson, L., Alphonse, N., Dickenson, R. E., Durbin, J. E., Glenn, J. S., Hartmann, R., Kotenko, S. V., Lazear, H. M., O’Brien, T. R., Odendall, C., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200653 · Cited by 204
Sumida, T. S., Cheru, N. T., & Hafler, D. A. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-00994-x · Cited by 201
Suen, H., Brown, R., Yang, S., Weatherburn, C., Ho, P. J., Woodland, N., Nassif, N., Barbaro, P., Bryant, C., Hart, D., et al. (2016) · Leukemia · doi:10.1038/leu.2016.84 · Cited by 198
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
Saura-Esteller, J., de Jong, M., King, L. A., Ensing, E., Winograd, B., de Gruijl, T. D., Parren, P. W. H. I., & van der Vliet, H. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915837 · Cited by 195
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M., Wang, M., Arnason, J., Purev, E., Maloney, D. G., Andreadis, C., Sehgal, A., et al. (2024) · Blood · doi:10.1182/blood.2023020854 · Cited by 189
Jegaskanda, S., Weinfurter, J. T., Friedrich, T. C., & Kent, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.03030-12 · Cited by 183
Immunomodulatory drugs: Oral and systemic adverse effects
Bascones-Martinez, A., Mattila, R., Gomez-Font, R., & Meurman, J. (2014) · Medicina Oral Patología Oral y Cirugia Bucal · doi:10.4317/medoral.19087 · Cited by 182
The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
Arts, R. J. W., Joosten, L. A. B., & Netea, M. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00298 · Cited by 177
From periphery to center stage: 50 years of advancements in innate immunity
Carpenter, S. B., & O'Neill, L. A. J. (2024) · Cell · doi:10.1016/j.cell.2024.03.036 · Cited by 176
The brave new world of innate lymphoid cells
Eberl, G., Di Santo, J. P., & Vivier, E. (2015) · Nature Immunology · doi:10.1038/ni.3059 · Cited by 173
Cavalli, G., Larcher, A., Tomelleri, A., Campochiaro, C., Della-Torre, E., De Luca, G., Farina, N., Boffini, N., Ruggeri, A., Poli, A., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00012-6 · Cited by 173
Memory B cells and plasma cells: The differentiative continuum of humoral immunity
Cancro, M. P., & Tomayko, M. M. (2021) · Immunological Reviews · doi:10.1111/imr.13016 · Cited by 173
Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm
Jain, A., & Pasare, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602000 · Cited by 172
den HERTOG, A. L., van MARLE, J., van VEEN, H. A., van't HOF, W., BOLSCHER, J. G. M., VEERMAN, E. C. I., & NIEUW AMERONGEN, A. V. (2005) · Biochemical Journal · doi:10.1042/bj20042099 · Cited by 171
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
Fultang, L., Panetti, S., Ng, M., Collins, P., Graef, S., Rizkalla, N., Booth, S., Lenton, R., Noyvert, B., Shannon-Lowe, C., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.025 · Cited by 169
The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity
Liu, N., Pang, X., Zhang, H., & Ji, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.814709 · Cited by 169
Alnefaie, A., Albogami, S. M., Asiri, Y. A., Ahmad, T., Alotaibi, S. S., Al-Sanea, M. M., & Althobaiti, H. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.797440 · Cited by 165
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Tang, L., Huang, Z., Mei, H., & Hu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01521-5 · Cited by 162
Fungal responses to reactive oxygen species
Aguirre, J., Hansberg, W., & Navarro, R. (2006) · Medical Mycology · doi:10.1080/13693780600900080 · Cited by 160
Targeting STING to promote antitumor immunity
Chin, E. N., Sulpizio, A., & Lairson, L. L. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.06.010 · Cited by 160
Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery
Khatoon, N., Zhang, Z., Zhou, C., & Chu, M. (2022) · Biomaterials Science · doi:10.1039/d1bm01664d · Cited by 147
Transmission of trained immunity and heterologous resistance to infections across generations
Katzmarski, N., Domínguez‐Andrés, J., Cirovic, B., Renieris, G., Ciarlo, E., Roy, D. L., Lepikhov, K., Kattler, K., Gasparoni, G., Händler, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01052-7 · Cited by 146
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
Iorio, R. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00916-w · Cited by 145
Zhao, W., Wang, B., Chen, L., Fu, W., Xu, J., Liu, J., Jin, S., Chen, Y., Cao, X.-M., Yang, Y., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01301-8 · Cited by 144
Tolerance in the Age of Immunotherapy
Bluestone, J. A., & Anderson, M. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1911109 · Cited by 140
Emerging roles of basophils in allergic inflammation
Miyake, K., & Karasuyama, H. (2017) · Allergology International · doi:10.1016/j.alit.2017.04.007 · Cited by 132
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
Korde, N., Carlsten, M., Lee, M.-J., Minter, A., Tan, E. M., Kwok, M., Manasanch, E. E., Bhutani, M., Tageja, N., Roschewski, M. J., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.103085 · Cited by 131
Mast cells as effector cells of innate immunity and regulators of adaptive immunity
Cardamone, C., Parente, R., Feo, G. D., & Triggiani, M. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.07.003 · Cited by 131
STING-associated lung disease in mice relies on T cells but not type I interferon
Luksch, H., Stinson, W. A., Platt, D. J., Qian, W., Kalugotla, G., Miner, C. A., Bennion, B. G., Gerbaulet, A., Rösen‐Wolff, A., & Miner, J. J. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.044 · Cited by 131
Teigler, J. E., Iampietro, M. J., & Barouch, D. H. (2012) · Journal of Virology · doi:10.1128/jvi.00740-12 · Cited by 128
Edelson, B. T., Bradstreet, T. R., Wumesh, K. C., Hildner, K., Herzog, J., Sim, J. E., Russell, J. H., Murphy, T. L., Unanue, E. R., & MURPHY, K. M. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025660 · Cited by 128
CAR-macrophage: An extensive immune enhancer to fight cancer
Wang, S., Yang, Y., Ma, P., Zha, Y., Zhang, J., Lei, A., & Li, N. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103873 · Cited by 124
Memory-T-Cell-Derived Interferon-γ Instructs Potent Innate Cell Activation for Protective Immunity
Soudja, S. M., Chandrabos, C., Yakob, E., Veenstra, M., Palliser, D., & Lauvau, G. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.005 · Cited by 122
Innate immune memory: Implications for host responses to damage‐associated molecular patterns
Crișan, T. O., Netea, M. G., & Joosten, L. A. B. (2016) · European Journal of Immunology · doi:10.1002/eji.201545497 · Cited by 120
Niu, M., Yi, M., Wu, Y., Lyu, L., He, Q., Yang, R., Zeng, L., Shi, J. Y., Zhang, J., Zhou, P., et al. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01487-5 · Cited by 120
STING regulates metabolic reprogramming in macrophages via HIF-1α during Brucella infection
Gomes, M. T. R., Guimarães, E. S., Marinho, F. V., Macedo, I., Aguiar, E. R. G. R., Barber, G. N., Moraes‐Vieira, P. M., Alves-Filho, J. C., & Oliveira, S. C. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009597 · Cited by 119
Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens
Tuffs, S. W., Haeryfar, S. M. M., & McCormick, J. K. (2018) · Pathogens · doi:10.3390/pathogens7020053 · Cited by 114
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
Quinn, K. M., Zak, D. E., Costa, A. D. S., Yamamoto, A., Kastenmüller, K., Hill, B. J., Lynn, G. M., Darrah, P. A., Lindsay, R. W. B., Wang, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78280 · Cited by 113
Type I Interferons Modulate CD8 + T Cell Immunity to mRNA Vaccines
Beuckelaer, A. D., Grooten, J., & Koker, S. D. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.006 · Cited by 111
Mechanisms of Immune Tolerance in Leukemia and Lymphoma
Curran, E. K., Godfrey, J. K., & Kline, J. P. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.004 · Cited by 111
Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing
Chathuranga, K., Weerawardhana, A., Dodantenna, N., & Lee, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00691-y · Cited by 111
Bartel, Y., Bauer, B., & Steinle, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00362 · Cited by 110
Toll-like receptors and B cells: functions and mechanisms
Buchta, C. M., & Bishop, G. A. (2014) · Immunologic Research · doi:10.1007/s12026-014-8523-2 · Cited by 110
Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders
Alemao, C. A., Budden, K. F., Gomez, H. M., Rehman, S. F., Marshall, J. E., Shukla, S. D., Donovan, C., Forster, S. C., Yang, I. A., Keely, S., et al. (2020) · Allergy · doi:10.1111/all.14548 · Cited by 110
Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways
Edgerton, M., Koshlukova, S. E., Araujo, M. W. B., Patel, R. C., Dong, J., & Bruenn, J. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3310-3316.2000 · Cited by 109
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
Chaintreuil, P., Kerreneur, E., Bourgoin, M., Savy, C., Favreau, C., Robert, G., Jacquel, A., & Auberger, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178337 · Cited by 106
Fungal infections: Immune defense, immunotherapies and vaccines
Loh, J. T., & Lam, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114775 · Cited by 103
Hagberg, N., Berggren, O., Leonard, D., Weber, G., Bryceson, Y. T., Alm, G. V., Eloranta, M., & Rönnblom, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003349 · Cited by 95
Vudhichamnong, K., Walker, D. M., & Ryley, H. C. (1982) · Archives of Oral Biology · doi:10.1016/0003-9969(82)90184-4 · Cited by 95
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Ren, H., Jia, W., Xie, Y., Yu, M., & Chen, Y. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00848c · Cited by 93
B cell memory: from generation to reactivation: a multipronged defense wall against pathogens
Syeda, M. Z., Tu, H., Huang, C., Huang, W., & Mu, Q. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01889-5 · Cited by 93
Type‐I IFN drives the differentiation of short‐lived effector CD8+ T cells in vivo
Wiesel, M., Crouse, J., Bedenikovic, G., Sutherland, A. P. R., Joller, N., & Oxenius, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201142091 · Cited by 91
Leivas, A., Pérez‐Martínez, A., Blanchard, M. J., Martín‐Clavero, E., Fernández, L., Lahuerta, J. J., & Martínez‐López, J. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1250051 · Cited by 91
Vaccine development: Current trends and technologies
Poria, R., Kala, D., Nagraik, R., Walia, Y., Dhir, S., Singh, B., Kaushik, N. K., Noorani, M. S., Kaushal, A., & Gupta, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122331 · Cited by 90
Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases
Mackern‐Oberti, J. P., Llanos, C., Vega, F., Salazar‐Onfray, F., Riedel, C. A., Bueno, S. M., & Kalergis, A. M. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.010 · Cited by 89
Courtney, A. N., Tian, G., & Metelitsa, L. S. (2022) · Blood · doi:10.1182/blood.2022016201 · Cited by 89
Weinhäuser, I., Pereira‐Martins, D. A., Almeida, L. Y., Hilberink, J. R., Silveira, D. R., Quek, L. S., Rojas, C. A. O., Araujo, C. L., Bianco, T. M., Lucena-Araujo, A. R., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf8522 · Cited by 88
Cited by
Suali, L., Chia, Y., Rustin, C., Lem, F. F., Ching, X. J., Mansur, M. A. B., Henry, Z. A., Chan, M. K. S., Wong, M. B. F., & Pan, S. Y. (2026) · Biotechnic & Histochemistry · doi:10.1080/10520295.2026.2714776 · Cited by 2
“…lymphocytes) populations, execute specialized functions in antigen detection, cytokine signaling, cytotoxicity, and immune coordination (Warrington et al. 2011; Iwasaki and Medzhitov 2015; Liu 2016; Zimmerman et al. 2020; Xia et al. 2021; Chi et al. 2024; Wang et al. 2024; Brancewicz et al. 2025).”
Metadata
- Authors
- Wang, R., Lan, C., Benlagha, K., Camara, N. O. S., Miller, H., Kubo, M., Heegaard, S., Lee, P., Yang, L., Forsman, H., Li, X., Zhai, Z., & Liu, C.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2024-09-15
- Volume
- 5
- Issue
- 10
- Pages
- e714-e714
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W4402553249
- Cited by
- 305
- References
- 267
- FWCI
- 41.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.